
Tenet Healthcare (THC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Tenet Healthcare (THC) last issued guidance on July 23, 2026 for fiscal year 2026. The company guided earnings per share in the range of $20.3 - $21.69, compared to a consensus EPS estimate of $17.81. Tenet Healthcare also guided revenue in the range of $21.9B - $22.5B for the period.
Compared to prior guidance, Tenet Healthcare raised its EPS outlook from a previous range of $16.38 - $18.68. On the revenue side, the company raised its revenue forecast from a prior range of $21.5B - $22.3B.
Tenet Healthcare has issued 25 guidance updates between October 20, 2022 and July 23, 2026. During this period, the company raised its outlook 17 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $4.20 | $4.17 | $4.06 | $3.34 |
| Actual | $6.12 | $4.82 | $4.70 | $3.70 |
| Surprise | +45.7% | +15.6% | +15.8% | +10.8% |
| Revenue | ||||
| Estimate | $5.42B | $5.39B | $5.46B | $5.24B |
| Actual | $5.63B | $5.37B | $5.53B | $5.29B |
| Surprise | +3.82% | -0.49% | +1.17% | +0.85% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $4.65 | $5.66 | $5.02 | $5.24 |
| Revenue | ||||
| Consensus | $5.50B | $5.76B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $6.12 | $4.20 | 45.7 % |
| Q1 | Apr 30, 2026 | $4.82 | $4.17 | 15.6 % |
| Q4 | Feb 11, 2026 | $4.70 | $4.06 | 15.8 % |
| Q3 | Oct 28, 2025 | $3.70 | $3.34 | 10.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $5.63B | $5.42B | 3.82 % |
| Q1 | Apr 30, 2026 | $5.37B | $5.39B | -0.49 % |
| Q4 | Feb 11, 2026 | $5.53B | $5.46B | 1.17 % |
| Q3 | Oct 28, 2025 | $5.29B | $5.24B | 0.85 % |